McKesson Corporation (NYSE:MCK) — Market Cap & Net Worth
Market Cap & Net Worth: McKesson Corporation (MCK)
McKesson Corporation (NYSE:MCK) has a market capitalization of $101.38 Billion ($101.38 Billion) as of September 21, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #249 globally and #129 in its home market, demonstrating a -0.70% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying McKesson Corporation's stock price $874.65 by its total outstanding shares 116590363 (116.59 Million). Also see MCK current and non-current assets for a full breakdown of the balance sheet.
McKesson Corporation Market Cap History: 2015 to 2026
McKesson Corporation's market capitalization history from 2015 to 2026. Data shows growth from $21.39 Billion to $101.98 Billion (15.52% CAGR). Also see McKesson Corporation operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
McKesson Corporation is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$63.07 Trillion | 0.19% | #102 of 503 |
Weight: McKesson Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
McKesson Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how McKesson Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check McKesson Corporation (MCK) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.25x
McKesson Corporation's market cap is 0.25 times its annual revenue
Latest Price to Earnings (P/E) Ratio
21.41x
McKesson Corporation's market cap is 21.41 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $17.17 Billion | $198.53 Billion | $5.18 Billion | 0.09x | 3.31x |
| 2018 | $12.29 Billion | $208.36 Billion | $67.00 Million | 0.06x | 183.43x |
| 2019 | $15.57 Billion | $214.32 Billion | $34.00 Million | 0.07x | 458.05x |
| 2020 | $19.79 Billion | $231.05 Billion | $900.00 Million | 0.09x | 21.99x |
| 2021 | $28.54 Billion | $238.23 Billion | -$4.54 Billion | 0.12x | N/A |
| 2022 | $43.33 Billion | $263.97 Billion | $1.11 Billion | 0.16x | 38.90x |
| 2023 | $53.79 Billion | $276.71 Billion | $3.56 Billion | 0.19x | 15.11x |
| 2024 | $66.45 Billion | $308.95 Billion | $3.00 Billion | 0.22x | 22.13x |
| 2025 | $95.64 Billion | $359.05 Billion | $3.29 Billion | 0.27x | 29.03x |
| 2026 | $101.98 Billion | $403.43 Billion | $4.76 Billion | 0.25x | 21.41x |
Competitor Companies of MCK by Market Capitalization
Companies near McKesson Corporation in the global market cap rankings as of September 21, 2026. Review McKesson Corporation tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to McKesson Corporation by market ranking:
- Cencora Inc. (NYSE:COR): Ranked #545 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #645 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1239 globally with a market cap of $20.83 Billion USD ( AU$29.44 Billion AUD).
- Sigma Healthcare Limited (F:S5YA): Ranked #1301 globally with a market cap of $19.74 Billion USD ( €16.88 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #545 | Cencora Inc. | NYSE:COR | $50.53 Billion | $308.78 |
| #645 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $225.38 |
| #1239 | Sigma Healthcare Ltd | AU:SIG | $20.83 Billion | AU$2.55 |
| #1301 | Sigma Healthcare Limited | F:S5YA | $19.74 Billion | €1.53 |
McKesson Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, McKesson Corporation's market cap moved from $21.39 Billion to $ 101.98 Billion, with a yearly change of 15.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $101.98 Billion | +6.63% |
| 2025 | $95.64 Billion | +43.93% |
| 2024 | $66.45 Billion | +23.53% |
| 2023 | $53.79 Billion | +24.13% |
| 2022 | $43.33 Billion | +51.83% |
| 2021 | $28.54 Billion | +44.23% |
| 2020 | $19.79 Billion | +27.06% |
| 2019 | $15.57 Billion | +26.72% |
| 2018 | $12.29 Billion | -28.40% |
| 2017 | $17.17 Billion | +11.95% |
| 2016 | $15.33 Billion | -28.30% |
| 2015 | $21.39 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 21st, 2026 the market cap of McKesson Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $101.38 Billion USD |
| MoneyControl | $101.38 Billion USD |
| MarketWatch | $101.38 Billion USD |
| marketcap.company | $101.38 Billion USD |
| Reuters | $101.38 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; d… Read more